Asarfi Hospital Ltd is Rated Buy by MarketsMOJO

Current Rating and Its Significance

MarketsMOJO’s Buy rating for Asarfi Hospital Ltd indicates a positive outlook on the stock’s future performance based on a comprehensive evaluation of its quality, valuation, financial trend, and technical indicators. This rating suggests that the stock is expected to deliver favourable returns relative to its peers and the broader market, making it an attractive option for investors seeking growth opportunities in the hospital sector.

Quality Assessment

As of 21 June 2026, Asarfi Hospital Ltd holds an average quality grade. This reflects a stable operational foundation with consistent profitability and manageable risk factors. The company has demonstrated a strong ability to service its debt, with a Debt to EBITDA ratio of just 1.96 times, signalling prudent financial management and a healthy balance sheet. Additionally, the company’s promoters maintain majority shareholding, which often aligns management interests with those of shareholders.

Valuation Attractiveness

The valuation grade for Asarfi Hospital Ltd is classified as very attractive. The company’s return on capital employed (ROCE) stands at a robust 15.6%, underscoring efficient use of capital to generate profits. Furthermore, the enterprise value to capital employed ratio is a low 3.5, indicating that the stock is reasonably priced relative to its capital base. The price-to-earnings-to-growth (PEG) ratio of 0.5 further supports the view that the stock is undervalued given its earnings growth prospects, making it a compelling buy for value-conscious investors.

Financial Trend and Growth Metrics

Financially, Asarfi Hospital Ltd is on a positive trajectory. The latest data as of 21 June 2026 shows that net sales have grown at an annualised rate of 27.7%, while operating profit has expanded even faster at 34.16%. The company has reported positive results for the last four consecutive quarters, with profit after tax (PAT) for the latest six months reaching ₹9.34 crores, reflecting a growth rate of 48.96%. Net sales for the same period stood at ₹91.34 crores, growing by 34.34%. The operating profit to interest coverage ratio is notably high at 10.87 times, indicating strong earnings relative to interest expenses and a comfortable margin of safety for creditors.

Technical Indicators and Market Performance

From a technical perspective, Asarfi Hospital Ltd exhibits a bullish grade. The stock has delivered impressive returns over various time frames, with a 1-year return of 70.68% and a 3-month gain of 44.45%. The 1-month and 6-month returns are also strong at 16.23% and 24.04%, respectively. Year-to-date, the stock has appreciated by 20.68%. These figures highlight sustained investor confidence and positive momentum in the stock price, supported by favourable market sentiment and technical strength.

Implications for Investors

For investors, the Buy rating on Asarfi Hospital Ltd signals an opportunity to participate in a company with solid fundamentals, attractive valuation, and strong growth prospects. The combination of steady financial performance, efficient capital utilisation, and positive technical trends suggests that the stock is well-positioned to continue delivering value. However, as with any investment, it is prudent to consider sector-specific risks and broader market conditions before making allocation decisions.

Stock Returns and Market Context

Examining the stock’s recent performance, Asarfi Hospital Ltd has shown resilience and strong upward momentum. The 1-day gain of 0.24% on 21 June 2026 reflects steady investor interest. Despite a slight 0.96% decline over the past week, the stock’s longer-term returns remain impressive. The 6-month return of 24.04% and the 1-year return of 70.68% significantly outperform many peers in the hospital sector and broader microcap universe. This performance is underpinned by the company’s robust earnings growth and operational efficiency.

Financial Health and Operational Efficiency

Asarfi Hospital Ltd’s financial health is further evidenced by its ability to generate consistent profits and maintain a strong interest coverage ratio. The operating profit to interest ratio of 10.87 times indicates that the company comfortably meets its interest obligations, reducing financial risk. The steady increase in net sales and operating profit over recent periods demonstrates effective management and operational scalability, which are critical for sustaining growth in the competitive healthcare sector.

Valuation Metrics Supporting the Buy Rating

The company’s valuation metrics reinforce the Buy rating. A PEG ratio of 0.5 suggests that the stock’s price growth has not yet fully reflected its earnings growth potential, offering upside for investors. The enterprise value to capital employed ratio of 3.5 is low relative to industry averages, indicating that the stock is trading at a discount to its capital base. This valuation, combined with a ROCE of 15.6%, highlights efficient capital deployment and attractive returns on investment.

Conclusion: A Compelling Investment Proposition

In summary, Asarfi Hospital Ltd’s Buy rating by MarketsMOJO is supported by a balanced assessment of quality, valuation, financial trends, and technical strength. The company’s solid fundamentals, attractive valuation, and positive market momentum make it a compelling choice for investors seeking exposure to the hospital sector’s growth potential. While the rating was last updated on 09 June 2026, the current data as of 21 June 2026 confirms the stock’s favourable position and growth prospects.

Investors should continue to monitor the company’s quarterly results and sector developments to ensure alignment with their investment objectives and risk tolerance.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →